Insider trade

CEO sold ~$2M of RMD shares in the open market

Traded Nov 7, 2025 · Filed Nov 11, 2025

ResMed|RMD

~$2M
Reported value · 8,011 sh @ $249.7532: 468K
Holds after · shares reported: -12.1%
stock since the trade · S&P 500 +13.9%, $251.49 → $221.15 on Oct 1

Why it stands out

The boss of ResMed| sold $2M of ResMed| shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 7, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 11, 2025

CEO$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,000,773

Shares × reported transaction price

Timing vs results

8 days after results of Oct 30, 2025, 83 days before results of Jan 29, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $251.49 on Nov 7, 2025, 23% above its 52-week low and 14% below its high, after a 7% drop over the previous 30 trading days

52-week range $204.54 (Apr 8, 2025) to $293.73 (Aug 22, 2025), 53% of the way up, from 250 adjusted closes. 30 trading days earlier: $270.27 on Sep 26, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-3.1%	-3.0%	-0.1%
30 days	-0.2%	-0.2%	+0.0%
90 days	+4.2%	+1.3%	+2.9%
180 days	-21.4%	+8.2%	-29.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0000943819-25-000095
Filed / recorded: Nov 11, 2025, 5:07 AM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: RESMED INC
Issuer CIK: 943819
Ticker: RMD
Reporting person: Michael J. Farrell
Relationship: Director, Officer
Officer title: Chairman and CEO
Security: ResMed Common Stock
Table: Non-derivative (Table I)
Transaction date: Nov 7, 2025
Transaction code: S
Shares / units: 8,011
Price per share: $249.7532
Acquired / disposed: Disposed (D)
Shares owned after: 467,866
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.
This transaction was executed in multiple trades at prices ranging from $248.13 - $251.46. The price reported above reflects the weighted average sale price.